Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF Breast Cancer Vaccine with Trastuzumab and Cyclophosphamide
NCT00399529Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Sep 2006
- Primary completion
- Feb 2010
- Modality
- Gene Editing, Prophylactic Vaccines, Gene Silencing
- Countries
- 1
01
Overview
A Phase 2 trial of SV-BR-1-GM in breast cancer, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Sep 2006; status: completed.
02
Drugs
SV-BR-1-GM
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00399529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00399529.